TEAS RF New Application

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88626812

Filing Date: 09/23/2019

To the Commissioner for Trademarks:

MARK: APTON BIOSYSTEMS (Standard Characters, see mark)
The literal element of the mark consists of APTON BIOSYSTEMS. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Apton Biosystems, Inc., a corporation of Delaware, having an address of
      6670 Owens Dr
      Pleasanton, California 94588
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 001:  Assays and reagents for scientific or research use; reagent kits for preparation or performance of single molecule assays for scientific or research use; reagent kits comprising components for single molecule assays for scientific or research use; kits comprising primarily of reagents, enzymes and/or nucleotides for genetic research diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic test kits for scientific use comprising reagents, flowcells, microfluidic devices, data analysis software and support documentation, namely, instructional manuals, therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small- molecule analysis, single nucleotide polymorphisms analysis, insertion and deletion mutations, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, detection of genomic rearrangements and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics, environmental monitoring, biosurveillance, agricultural inspection, forensic testing of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors namely, diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small- molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 005:  Diagnostic preparations for medical and veterinary medical purposes, namely, for the preparation of samples, the modification and manipulation of samples and for the marking, separation, isolation, purification and reproduction and analysis of biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances; chemical, biochemical and biotechnological products, namely, reagents and solvents for medical use for the preparation of samples, the modification and the manipulation of samples and for performing marking, separation, isolation, purification, reproduction and analysis methods for biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes; kits comprising diagnostic preparations for medical and veterinary medical diagnostic purposes for the preparation of samples, the modification and manipulation of samples and for marking, separation, isolation, purification, reproduction and analysis of biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances in the nature of nucleic acids from biological or biochemical sample material diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical and scientific use; diagnostic test kits for medical use comprising primarily reagents, flowcells, solid matrix materials, microfluidic devices, software sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising primarily reagents, flowcells, solid matrix materials, microfluidic devices sold as a unit and instructional manuals therefor; medical diagnostic kits comprising medical diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type in the nature of equipment, namely, medical diagnostic immune-assays for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, insertion and deletion polymorphisms, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations and structural variants, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for diagnostics for a variety of uses in health care namely, medical diagnostic reagents for RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis, namely, reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 009:  Laboratory instruments for scientific research, namely, optical detectors for genetic sequencing and biochemical analysis; scientific equipment and instruments, namely, semiconductor chips with integrated sensors for nucleic acid sequencing, semiconductor chip readers and related computer software used for nucleic acid sequencing and analysis; nucleic acid polymer particles for use in genetic sequencing; genome analyzer machines and related computer operating software; computer software for monitoring of genome analyzer machines from handheld or mobile wireless communication devices capable of voice, data and/or image transmission; computer software for the interpretation of data from the genome analyzer machines; computer software for displaying, organizing, storing, sharing and interpreting of DNA data
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Computer services, namely, providing an online community for subscribers to participate by sharing and posting articles, videos, and other content, namely, findings in the fields of nucleic acid sequencing and genotyping, medical diagnostics, clinical diagnostics, medical research, clinical research, life sciences, biology, molecular diagnostics, laboratory medicine, biotechnology, agriculture, forensics, and genetics; research services, namely, case studies in the fields of and for use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, metagenomics, biotechnology, agriculture, forensics, food safety, and genetics; leasing of laboratory equipment, namely, genomic sequencers and molecular diagnostics, scientific apparatus and instruments, namely, genomic sequencers and molecular diagnostics; medical research services in the field of genotyping, diagnostics, molecular pathology, molecular diagnostics, laboratory medicine, and oncology; DNA sequencing, screening, and analysis services for research purposes; DNA sequencing, screening, and analysis services for use in agricultural, environmental and forensic applications; DNA sequencing, screening, and analysis services for medical research purposes; nucleic acid sequencing, screening, and analysis services for medical research purposes; genomic sequencing, screening, and analysis services for medical research purposes; genetic analysis and reporting services for medical research purposes; providing temporary use of nondownloadable software for displaying, organizing, storing, sharing and interpreting of DNA data; genomic sequencing, screening, and analysis services for non-medical purposes; nucleic acid sequencing, screening, and analysis services for non-medical diagnostic purposes; genetic analysis and reporting services for non-medical purposes; providing temporary use of nondownloadable software for interpretation of data from genome analyzer machines
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Medical testing for diagnostic or treatment purposes; DNA sequencing, screening, and analysis services for medical diagnostic purposes; nucleic acid sequencing, screening, and analysis services for medical diagnostic purposes; genomic sequencing, screening, and analysis services for medical diagnostic purposes; genetic analysis and reporting services for medical diagnostic purposes; medical diagnostic testing, monitoring and reporting services in the field of infectious disease identification and surveillance
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The applicant hereby appoints Aaron D. Hendelman. Other appointed attorneys are John L. Slafsky, Alyssa M. Worsham, Christine K. Au-Yeung, Brandon P. Leahy, Chelsea Carbone, Susanna P. Lichter. Aaron D. Hendelman of WILSON SONSINI GOODRICH & ROSATI, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      650 Page Mill Road
      Palo Alto, California 94304-1050
      United States
      650-493-9300(phone)
      650-493-6811(fax)
      trademarks@wsgr.com (authorized).
The attorney docket/reference number is 55495.TM1001.
Aaron D. Hendelman submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:

Aaron D. Hendelman

WILSON SONSINI GOODRICH & ROSATI

650 Page Mill Road

Palo Alto, California 94304-1050

650-493-9300(phone)

650-493-6811(fax)

trademarks@wsgr.com (authorized). Email Authorization: I authorize the USPTO to send email correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the email address provided in this application. I understand that a valid email address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $1375 has been submitted with the application, representing payment for 5 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Ellen M. Beasley/   Date: 09/23/2019
Signatory's Name: Ellen M. Beasley
Signatory's Position: CEO
Payment Sale Number: 88626812
Payment Accounting Date: 09/23/2019

Serial Number: 88626812
Internet Transmission Date: Mon Sep 23 12:54:33 EDT 2019
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XX-2019092312543329
2322-88626812-6108e327438a2e2576fb4501c1
58c9f24b697421511af6e0b7184c419a3bcb47-D
A-54331710-20190916212710462865